⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17501260 | 0.97 | — | — | |
| SCHEMBL5794937 | 0.69 | — | — | |
| Sulfurous Acid SCHEMBL25287274 | 0.69 | — | — | |
| SCHEMBL23829641 | 0.69 | — | — | |
| SCHEMBL10776738 | 0.69 | MEN1 (0.33) | — | |
| SCHEMBL10012479 | 0.69 | — | — | |
| SCHEMBL25453246 | 0.67 | — | — | |
| Allylamine SCHEMBL7866713 | 0.67 | — | — | |
| Sulfurous Acid SCHEMBL6062465 | 0.67 | — | — | |
| SCHEMBL3240865 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 614 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240191012-A1 | Method of Making a Fluoropolymer Dispersion Having a Low Amount of Perfluoroalkanoic Acids or Salts Thereof and the Fluoropolymer Comprises a Low Ionic End Group Ratio | 3M INNOVATIVE PROPERTIES COMPANY | 2024-06-13 | — | — | US | claimed |
| WO-2024026273-A1 | THERAPY FOR REDUCED OTOTOXICITY FROM CHEMOTHERAPEUTIC AGENT WITH PENTAAZA MACROCYCLIC RING COMPLEX | GALERA LABS, LLC (US) | 2024-02-01 | — | — | WO | claimed |
| US-20230218633-A1 | METHODS OF TREATING ORAL MUCOSITIS | GALERA LABS, LLC | 2023-07-13 | — | — | US | claimed |
| US-20230158042-A1 | COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX AND HORMONE THERAPY AGENT | BIOSSIL INC. (CA) | 2023-05-25 | — | — | US | claimed |
| US-20230149358-A1 | COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX AND HORMONE THERAPY AGENT | BIOSSIL INC. (CA) | 2023-05-18 | — | — | US | claimed |
| EP-4157242-A1 | COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX AND HORMONE THERAPY AGENT | Galera Labs, LLC (US) | 2023-04-05 | — | — | EP | claimed |
| US-11612608-B2 | Methods of treating oral mucositis | GALERA LABS, LLC (US) | 2023-03-28 | — | — | US | claimed |
| WO-2023009500-A1 | PENTAAZA MACROCYCLIC RING COMPLEX FOR ENHANCED SURGICAL TREATMENT | GALERA LABS, LLC (US) | 2023-02-02 | — | — | WO | claimed |
| US-20220227798-A1 | MANUFACTURE METHOD FOR AQUEOUS FORMULATION OF MANGANESE-CONTAINING COORDINATION COMPLEX, FORMULATION, AND METHOD OF TREATMENT | GALERA LABS, LLC | 2022-07-21 | — | — | US | claimed |
| US-20220118119-A1 | COMBINATION CANCER IMMUNOTHERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX | BIOSSIL INC. (CA) | 2022-04-21 | — | — | US | claimed |
| CN-1087080-A | The phenyl alkane acids class of treatment cardiovascular disorder | PFIZER RES & DEV (IE) | 1994-05-25 | — | — | CN | claimed |
| WO-1993002090-A1 | MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | MONSANTO COMPANY (US) | 1993-02-04 | — | — | WO | claimed |
| EP-0524161-A1 | Manganese complexes of nitrogen containing macrocyclic ligands effective as catalysts for dismutating superoxide | MONSANTO COMPANY (US) | 1993-01-20 | — | — | EP | claimed |
| US-4740596-A | Process for preparation of 4-sulfonylthio azetidinone derivatives | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1988-04-26 | — | — | US | claimed |
| US-4713452-A | Process for preparation of azetidinone derivatives | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1987-12-15 | — | — | US | claimed |
| US-4632960-A | STRENG, NON CORROSIVE, NON SHRINKING; METAL-FREE EMULSION POLYMERIZATION | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1986-12-30 | — | — | US | claimed |
| US-4613680-A | ISOMERIZATION | TORAY INDUSTRIES, INC. (JP) | 1986-09-23 | — | — | US | claimed |
| US-4559346-A | Certain N-octahydro-indolizinebenzamides and their use in treating psychosis, cardiac arrhythmia and hypertension | BEECHAM GROUP P.L.C. (GB) | 1985-12-17 | — | — | US | claimed |
| EP-0010440-B1 | PYROMELLITIC DIIMIDES, PROCESSES FOR THEIR PREPARATION, THESE COMPOUNDS IN ORALLY ADMINISTRABLE FORM FOR USE IN INCREASING THE FEED EFFICIENCY OF A RUMINANT ANIMAL AND COMPOSITIONS FOR THIS PURPOSE CONTAINING THEM | MERCK & CO. INC. (US) | 1983-01-26 | — | — | EP | claimed |
| EP-0010440-A1 | Pyromellitic diimides, processes for their preparation, these compounds in orally administrable form for use in increasing the feed efficiency of a ruminant animal and compositions for this purpose containing them | MERCK & CO. INC. (US) | 1980-04-30 | — | — | EP | claimed |